Diacerhein blocks iron regulatory protein activation in inflamed human monocytes.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Life Science

• Publication date

  1998-08-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(98)00392-0PMID 9771919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diacerein

  2012cited by this paper
• The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium

  1998cited by this paper
• Effects of diacerhein on granuloma induced cartilage breakdown in the mouse.

  1998cited by this paper
• Endogenously produced urokinase amplifies tumor necrosis factor‐α secretion by THP‐1 mononuclear phagocytes

  1996cited by this paper
• Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways

  1996cited by this paper
• Structure-Function Relationship of Lipoprotein Lipase-mediated Enhancement of Very Low Density Lipoprotein Binding and Catabolism by the Low Density Lipoprotein Receptor

  1996cited by this paper
• Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH2-terminal Kinases*

  1996cited by this paper
• Protein-tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1beta and NFkappaB activation, but not NFkappaB nuclear translocation.

  1996cited by this paper
• Iron regulatory proteins 1 and 2

  1996cited by this paper
• Protein-tyrosine Kinase Activation Is Required for Lipopolysaccharide Induction of Interleukin 1β and NFκB Activation, but Not NFκB Nuclear Translocation*

  1996cited by this paper
• Nitric oxide in inflammation and immune response.

  1995cited by this paper
• A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages.

  1995cited by this paper
• Nitric-oxide-mediated activation of iron-regulatory protein controls hepatic iron metabolism during acute inflammation.

  1995cited by this paper
• Induction of Ferritin Synthesis by Oxidative Stress

  1995cited by this paper
• Rapid responses to oxidative stress mediated by iron regulatory protein.

  1995cited by this paper
• Nitric oxide synthase: MRNA expression of different isoforms in human monocytes/macrophages

  1994cited by this paper
• Transferrin receptor gene expression during rat liver regeneration. Evidence for post-transcriptional regulation by iron regulatory factorB, a second iron-responsive element-binding protein.

  1994cited by this paper
• Diacerhein in the treatment of osteoarthritis of the hip.

  1994cited by this paper
• Regulating the fate of mRNA: the control of cellular iron metabolism.

  1993cited by this paper
• Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.

  1993cited by this paper
• A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA.

  1989cited by this paper
• Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs.

  1988cited by this paper
• Rhein: an anthraquinone that modulates superoxide anion production from human neutrophils

  1987cited by this paper

• COMPOUNDS FOR THE TREATMENT OR PREVENTION OF WASCULAR DISEASES

  2017cites this paper
• USE OF RHEN OR DIACERHEN COMPOUNDS FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES Inventors:

  2017cites this paper
• Diacerein decreases visceral pain through inhibition of glutamatergic neurotransmission and cytokine signaling in mice.

  2012cites this paper
• Diacerein decreases TNF-α and IL-1β levels in peritoneal fluid and prevents Baker’s yeast-induced fever in young rats

  2010cites this paper
• Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects.

  2002cites this paper
• Diacerein as a disease-modulating agent in osteoarthritis

  2001cites this paper